Skip to Content
Merck
CN
  • Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

Bioorganic & medicinal chemistry letters (2005-10-11)
Katrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, Holger Kühne, David W Banner, Hans-Joachim Böhm, Martin Stahl, Jean Ackermann, Leo Alig, Lutz Weber, Hans Peter Wessel, Markus A Riederer, Thomas B Tschopp, Thierry Lavé
ABSTRACT

We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
D−(−)-α-Phenylglycine, 99%
Sigma-Aldrich
2-Phenylglycine, 95%
Sigma-Aldrich
L−(+)-α-Phenylglycine, 99%